Zomedica Corp.(TSX Venture Exchange : ZOM)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|LLY||Eli Lilly & Co.||1.08%||365.63||1.1%||$1192.52m|
|JNJ||Johnson & Johnson||0.12%||177.22||0.7%||$1097.25m|
|MRK||Merck & Co., Inc.||0.60%||107.46||0.7%||$994.87m|
|BMY||Bristol-Myers Squibb Co.||0.16%||79.27||1.1%||$751.13m|
|IDXX||IDEXX Laboratories, Inc.||-1.24%||411.36||3.9%||$222.64m|
|HZNP||Horizon Therapeutics Plc||0.97%||78.28||5.4%||$201.37m|
|ALNY||Alnylam Pharmaceuticals, Inc.||2.03%||212.72||8.0%||$159.13m|
|NVO||Novo Nordisk A/S||0.86%||118.84||0.1%||$155.62m|
Zomedica Corp. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. It offers products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Its TRUFORMA biosensor platform is designed to assist practitioners in the diagnosis of complex conditions. The company was founded by Gerald L. Solensky. on January 7, 2013 and is headquartered in Ann Arbor, MI.